Cargando…
Herpes zoster vaccine in Korea
Herpes zoster and post-herpetic neuralgia deteriorate the quality of life because of severe pain and complications, and cause considerable social and economic burden of disease. In 2012, herpes zoster vaccine was released in Korea. The efficacy of herpes zoster vaccine is known to be 51.3-66.5% amon...
Autor principal: | Choi, Won Suk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Vaccine Society
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3710929/ https://www.ncbi.nlm.nih.gov/pubmed/23858399 http://dx.doi.org/10.7774/cevr.2013.2.2.92 |
Ejemplares similares
-
Physician Attitudes toward the Herpes Zoster Vaccination in South Korea
por: Yang, Tae Un, et al.
Publicado: (2014) -
Herpes Zoster Vaccination
por: Kim, Kyung Hoon
Publicado: (2013) -
Prevention of Herpes Zoster: A Focus on the Effectiveness and Safety of Herpes Zoster Vaccines
por: Marra, Yasmin, et al.
Publicado: (2022) -
Status of Herpes Zoster and Herpes Zoster Vaccines in 2023: A position paper
por: García, José María Molero, et al.
Publicado: (2023) -
Herpes Zoster Vaccines
por: Harbecke, Ruth, et al.
Publicado: (2021)